Prevention and treatment of viral diarrhea in pediatrics

References

• King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm. Rep.52(RR-16), 1–16 (2003).
   PubMedGoogle Scholar
• Guerrant RL, Van Gilder T, Steiner TS et al. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis.32(3), 331–351 (2001).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med.354(1), 23–33 (2006).
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med.354(1), 11–22 (2006).
   PubMed Web of Science ®Google Scholar
• Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg. Infect. Dis.5(5), 607–625 (1999).
   PubMed Web of Science ®Google Scholar
• Jones TF, Scallan E, Angulo FJ. FoodNet: overview of a decade of achievement. Foodborne Pathog. Dis.4(1), 60–66 (2007).
   PubMed Web of Science ®Google Scholar
• Kapikian AZ. Viral gastroenteritis. JAMA269(5), 627–630 (1993).
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N. Engl. J. Med.361(18), 1776–1785 (2009).
   PubMed Web of Science ®Google Scholar
• Gary GW Jr, Hierholzer JC, Black RE. Characteristics of noncultivable adenoviruses associated with diarrhea in infants: a new subgroup of human adenoviruses. J. Clin. Microbiol.10(1), 96–103 (1979).
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect. Dis.4(2), 91–99 (2004).
   PubMed Web of Science ®Google Scholar
• Bresee JS. Viral gastroenteritis. In: Principles and Practice of Pediatric Infectious Diseases (3rd Edition). Long SS (Ed.). Churchill Livingstone, An Imprint of Elsevier Ltd, PA, USA (2008).
   Google Scholar
• Burton-MacLeod JA, Kane EM, Beard RS, Hadley LA, Glass RI, Ando T. Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples. J. Clin. Microbiol.42(6), 2587–2595 (2004).
   PubMed Web of Science ®Google Scholar
• Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N. Engl. J. Med.361(20), 1935–1944 (2009).
   PubMed Web of Science ®Google Scholar
• Pang XL, Vesikari T. Human astrovirus-associated gastroenteritis in children under 2 years of age followed prospectively during a rotavirus vaccine trial. Acta Paediatr.88(5), 532–536 (1999).
   PubMed Web of Science ®Google Scholar
• Moreno-Espinosa S, Farkas T, Jiang X. Human caliciviruses and pediatric gastroenteritis. Semin. Pediatr. Infect. Dis.15(4), 237–245 (2004).
   PubMedGoogle Scholar
• Pang XL, Honma S, Nakata S, Vesikari T. Human caliciviruses in acute gastroenteritis of young children in the community. J. Infect. Dis.181(Suppl. 2), S288–S294 (2000).
   PubMed Web of Science ®Google Scholar
• WHO. Rotavirus vaccines. Wkly Epidemiol. Rec.82(32), 285–295 (2007).
   PubMedGoogle Scholar
• Glass RI, Parashar UD, Bresee JS et al. Rotavirus vaccines: current prospects and future challenges. Lancet368(9532), 323–332 (2006).
   PubMed Web of Science ®Google Scholar
• Fischer TK, Viboud C, Parashar U et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993–2003. J. Infect. Dis.195(8), 1117–1125 (2007).
   PubMed Web of Science ®Google Scholar
• Payne DC, Staat MA, Edwards KM et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics122(6), 1235–1243 (2008).
   PubMed Web of Science ®Google Scholar
• Pitzer VE, Viboud C, Simonsen L et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science325(5938), 290–294 (2009).
   PubMed Web of Science ®Google Scholar
• Staat MA, Azimi PH, Berke T et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr. Infect. Dis. J.21(3), 221–227 (2002).
   PubMed Web of Science ®Google Scholar
• Rodriguez WJ, Kim HW, Arrobio JO et al. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J. Pediatr.91(2), 188–193 (1977).
   PubMed Web of Science ®Google Scholar
• Anderson E. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect. Dis.8, 642–649 (2008).
   PubMed Web of Science ®Google Scholar
• Ansari SA, Sattar SA, Springthorpe VS, Wells GA, Tostowaryk W. Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J. Clin. Microbiol.26(8), 1513–1518 (1988).
   PubMed Web of Science ®Google Scholar
• Pickering LK, Bartlett AV 3rd, Reves RR, Morrow A. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J. Pediatr.112(3), 361–365 (1988).
   PubMed Web of Science ®Google Scholar
• Fischer TK, Bresee JS, Glass RI. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine22(Suppl. 1), S49–S54 (2004).
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ et al. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med.335(14), 1022–1028 (1996).
   PubMed Web of Science ®Google Scholar
• Freeman MM, Kerin T, Hull J et al. Phylogenetic analysis of novel G12 rotaviruses in the United States: a molecular search for the origin of a new strain. J. Med. Virol.81(4), 736–746 (2009).
   PubMed Web of Science ®Google Scholar
• Pang XL, Joensuu J, Vesikari T. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr. Infect. Dis. J.18(5), 420–426 (1999).
   PubMed Web of Science ®Google Scholar
• Patel MM, Hall AJ, Vinje J, Parashar UD. Noroviruses: a comprehensive review. J. Clin. Virol.44(1), 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinje J, Parashar UD. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis.14(8), 1224–1231 (2008).
   PubMed Web of Science ®Google Scholar
• Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med.297(2), 86–89 (1977).
   PubMed Web of Science ®Google Scholar
• Musher DM, Musher BL. Contagious acute gastrointestinal infections. N. Engl. J. Med.351(23), 2417–2427 (2004).
   PubMed Web of Science ®Google Scholar
• Atmar RL, Opekun AR, Gilger MA et al. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis.14(10), 1553–1557 (2008).
   PubMed Web of Science ®Google Scholar
• Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol. Infect.124(3), 481–487 (2000).
   PubMed Web of Science ®Google Scholar
• Huang P, Farkas T, Marionneau S et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis.188(1), 19–31 (2003).
   PubMed Web of Science ®Google Scholar
• Said MA, Perl TM, Sears CL. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. Clin. Infect. Dis.47(9), 1202–1208 (2008).
   PubMed Web of Science ®Google Scholar
• Fankhauser RL, Noel JS, Monroe SS, Ando T, Glass RI. Molecular epidemiology of “Norwalk-like viruses” in outbreaks of gastroenteritis in the United States. J. Infect. Dis.178(6), 1571–1578 (1998).
   PubMed Web of Science ®Google Scholar
• Fankhauser RL, Monroe SS, Noel JS et al. Epidemiologic and molecular trends of “Norwalk-like viruses” associated with outbreaks of gastroenteritis in the United States. J. Infect. Dis.186(1), 1–7 (2002).
   PubMed Web of Science ®Google Scholar
• Dennehy PH, Nelson SM, Spangenberger S, Noel JS, Monroe SS, Glass RI. A prospective case-control study of the role of astrovirus in acute diarrhea among hospitalized young children. J. Infect. Dis.184(1), 10–15 (2001).
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Herrmann JE, Blacklow NR et al. The frequency of astrovirus as a cause of diarrhea in Baltimore children. Pediatr. Infect. Dis. J.11(7), 587–589 (1992).
   PubMed Web of Science ®Google Scholar
• Mitchell DK, Matson DO, Cubitt WD et al. Prevalence of antibodies to astrovirus types 1 and 3 in children and adolescents in Norfolk, Virginia. Pediatr. Infect. Dis. J.18(3), 249–254 (1999).
   PubMed Web of Science ®Google Scholar
• Ford-Jones EL, Mindorff CM, Gold R, Petric M. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am. J. Epidemiol.131(4), 711–718 (1990).
   PubMed Web of Science ®Google Scholar
• Kotloff KL, Losonsky GA, Morris JG Jr, Wasserman SS, Singh-Naz N, Levine MM. Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics84(2), 219–225 (1989).
   PubMed Web of Science ®Google Scholar
• Takiff HE, Straus SE, Garon CF. Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells. Lancet2(8251), 832–834 (1981).
   PubMed Web of Science ®Google Scholar
• Dennehy PH. Transmission of rotavirus and other enteric pathogens in the home. Pediatr. Infect. Dis. J.19(10 Suppl.), S103–S105 (2000).
   PubMed Web of Science ®Google Scholar
• Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. Effectiveness of liquid soap and hand sanitizer against norwalk virus on contaminated hands. Appl. Environ. Microbiol. DOI: 10.1128/AEM.01729-09 (2009) (Epub ahead of print).
   Google Scholar
• Fewtrell L, Kaufmann RB, Kay D, Enanoria W, Haller L, Colford JM Jr. Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis. Lancet Infect. Dis.5(1), 42–52 (2005).
   PubMed Web of Science ®Google Scholar
• Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect. Dis.3(5), 275–281 (2003).
   PubMed Web of Science ®Google Scholar
• Luby SP, Agboatwalla M, Feikin DR et al. Effect of handwashing on child health: a randomised controlled trial. Lancet366(9481), 225–233 (2005).
   PubMed Web of Science ®Google Scholar
• Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year?. Lancet361(9376), 2226–2234 (2003).
   PubMed Web of Science ®Google Scholar
• Victora CG, Smith PG, Vaughan JP et al. Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet2(8554), 319–322 (1987).
   PubMed Web of Science ®Google Scholar
• WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet355(9202), 451–455 (2000).
   PubMed Web of Science ®Google Scholar
• Barreto ML, Santos LM, Assis AM et al. Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil. Lancet344(8917), 228–231 (1994).
   PubMed Web of Science ®Google Scholar
• Fischer Walker CL, Black RE. Micronutrients and diarrheal disease. Clin. Infect. Dis.45(Suppl. 1), S73–S77 (2007).
   PubMed Web of Science ®Google Scholar
• Sazawal S, Black RE, Ramsan M et al. Effect of zinc supplementation on mortality in children aged 1–48 months: a community-based randomised placebo-controlled trial. Lancet369(9565), 927–934 (2007).
   PubMed Web of Science ®Google Scholar
• Tielsch JM, Khatry SK, Stoltzfus RJ et al. Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial. Lancet370(9594), 1230–1239 (2007).
   PubMed Web of Science ®Google Scholar
• Perez-Schael I, Guntinas MJ, Perez M et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med.337(17), 1181–1187 (1997).
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med.344(8), 564–572 (2001).
   PubMed Web of Science ®Google Scholar
• Smith PJ, Schwartz B, Mokdad A, Bloch AB, McCauley M, Murphy TV. The first oral rotavirus vaccine, 1998–1999: estimates of uptake from the National Immunization Survey. Public Health Rep.118(2), 134–143 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson EJ. Importance of on-time RotaTeq vaccination and long-term active surveillance. Pediatrics122(5), 1153–1154; author reply 1154 (2008).
   PubMed Web of Science ®Google Scholar
• Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics123(5), 1412–1420 (2009).
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline. Rotarix Summary of Product Characteristics. GlaxoSmithKline Biologicals, Rixensart, Belgium (2008).
   Google Scholar
• Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.58(RR-2), 1–25 (2009).
   PubMedGoogle Scholar
• Dennehy PH, Goveia MG, Dallas MJ, Heaton PM. The integrated Phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Int. J. Infect. Dis.11(Suppl. 2), S36–S42 (2007).
   PubMed Web of Science ®Google Scholar
• Block SL, Vesikari T, Goveia MG et al. Efficacy, immunogenicity, and safety of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics119(1), 11–18 (2007).
   PubMed Web of Science ®Google Scholar
• Haber P, Patel M, Izurieta HS et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics121(6), 1206–1212 (2008).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet370(9601), 1757–1763 (2007).
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA301(21), 2243–2251 (2009).
   PubMed Web of Science ®Google Scholar
• Zaman K, Sack DA, Yunus M et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine27(9), 1333–1339 (2009).
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Sani-Grosso R, Yuan G et al. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Pediatr. Infect. Dis. J.27(10), 874–880 (2008).
   PubMed Web of Science ®Google Scholar
• De Vos B, Han HH, Bouckenooghe A et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr. Infect. Dis. J.28(4), 261–266 (2009).
   PubMed Web of Science ®Google Scholar
• Givon-Lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children. Vaccine26(46), 5798–5801 (2008).
   PubMed Web of Science ®Google Scholar
• Tate JE, Panozzo CA, Payne DC et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics124(2), 465–471 (2009).
   PubMed Web of Science ®Google Scholar
• Delayed onset and diminished magnitude of rotavirus activity – United States, November 2007–May 2008. MMWR57(25), 697–700 (2008).
   PubMedGoogle Scholar
• Payne DC, Parashar UD. Epidemiological shifts in severe acute gastroenteritis in US children: will rotavirus vaccination change the picture?. J. Pediatr.153(6), 737–738 (2008).
   PubMed Web of Science ®Google Scholar
• Clark HF, Lawley D, Mallette LA, DiNubile MJ, Hodinka RL. Decline in cases of rotavirus gastroenteritis presenting to the Children’s Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin. Vaccine Immunol.16(3), 382–386 (2009).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Glass RI. Rotavirus vaccines – early success, remaining questions. N. Engl. J. Med.360(11), 1063–1065 (2009).
   PubMed Web of Science ®Google Scholar
• Gurgel RQ, Cuevas LE, Vieira SC et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerging Infect. Dis.13(10), 1571–1573 (2007).
   PubMed Web of Science ®Google Scholar
• Nakagomi T, Cuevas LE, Gurgel RG et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch. Virol.153(3), 591–593 (2008).
   PubMed Web of Science ®Google Scholar
• Leite JP, Carvalho-Costa FA, Linhares AC. Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem. Inst. Oswaldo Cruz103(8), 745–753 (2008).
   PubMed Web of Science ®Google Scholar
• Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD. Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg.Infect. Dis.14(5), 863–865 (2008).
   PubMed Web of Science ®Google Scholar
• Antunes H, Afonso A, Iturriza M et al. G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population. J. Clin. Virol.45(1), 76–78 (2009).
   PubMed Web of Science ®Google Scholar
• Dey SK, Hayakawa Y, Rahman M et al. G2 strain of rotavirus among infants and children, Bangladesh. Emerg. Infect. Dis.15(1), 91–94 (2009).
   PubMed Web of Science ®Google Scholar
• Daskalaki I, Spain CV, Long SS, Watson B. Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use. Pediatrics122(1), E33–E38 (2008).
   PubMed Web of Science ®Google Scholar
• Werther RL, Crawford NW, Boniface K, Kirkwood CD, Smart JM. Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J. Allergy Clin. Immunol.124(3), 600 (2009).
   PubMed Web of Science ®Google Scholar
• Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost–effectiveness analysis of a rotavirus immunization program for the United States. JAMA279(17), 1371–1376 (1998).
   PubMed Web of Science ®Google Scholar
• Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost–effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics119(4), 684–697 (2007).
   PubMed Web of Science ®Google Scholar
• Shim E, Galvani AP. Impact of transmission dynamics on the cost–effectiveness of rotavirus vaccination. Vaccine27(30), 4025–4030 (2009).
   PubMed Web of Science ®Google Scholar
• Patel MM, Clark AD, Glass RI et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine27(22), 2916–2922 (2009).
   PubMed Web of Science ®Google Scholar
• Meeting of the immunization Strategic Advisory Group of Experts, April 2009 – conclusions and recommendations. Wkly Epidemiol. Rec.84(23), 220–236 (2009).
   PubMedGoogle Scholar
• Jiang X, Wang M, Graham DY, Estes MK. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol.66(11), 6527–6532 (1992).
   PubMed Web of Science ®Google Scholar
• Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Estes MK. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin. Immunol.108(3), 241–247 (2003).
   PubMed Web of Science ®Google Scholar
• Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program?. Clin. Infect. Dis.44(12), 1532–1535 (2007).
   PubMed Web of Science ®Google Scholar
• Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. Br. Med. J.323(7304), 81–85 (2001).
   PubMed Web of Science ®Google Scholar
• Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst. Rev.3, CD005436 (2008).
   Google Scholar
• Szymanski H, Pejcz J, Jawien M, Chmielarczyk A, Strus M, Heczko PB. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains – a randomized, double-blind, placebo-controlled trial. Aliment. Pharmacol. Ther.23(2), 247–253 (2006).
   PubMed Web of Science ®Google Scholar
• Freedman SB. Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy. Expert Opin. Pharmacother.8(11), 1651–1665 (2007).
   PubMed Web of Science ®Google Scholar
• Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N. Engl. J. Med.354(16), 1698–1705 (2006).
   PubMed Web of Science ®Google Scholar
• Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N. Engl. J. Med.343(7), 463–467 (2000).
   PubMed Web of Science ®Google Scholar
• Rossignol JF, Abu-Zekry M, Hussein A, Santoro MG. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet368(9530), 124–129 (2006).
   PubMed Web of Science ®Google Scholar
• Rossignol JF, El-Gohary YM. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment. Pharmacol. Ther.24(10), 1423–1430 (2006).
   PubMed Web of Science ®Google Scholar
• Teran CG, Teran-Escalera CN, Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int. J. Infect. Dis.13(4), 518–523 (2009).
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Ison MG. Adenoviral Infections In Transplant Recipients. In: Emerging Infections 8. Scheld WM, Hughes JM (Eds). ASM Press, Washington, DC, USA, 75–91 (2008).
   Google Scholar
• Anderson EJ, Guzman-Cottrill JA, Kletzel M et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr. Transplant.12(2), 219–227 (2008).
   PubMed Web of Science ®Google Scholar
• Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant.7(7), 388–394 (2001).
   PubMed Web of Science ®Google Scholar
• Guarino A, Canani RB, Russo S et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics93(1), 12–16 (1994).
   PubMed Web of Science ®Google Scholar
• LoBue AD, Lindesmith L, Yount B et al. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine24(24), 5220–5234 (2006).
   PubMed Web of Science ®Google Scholar
• LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS. a-virus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J. Virol.83(7), 3212–3227 (2009).
   PubMed Web of Science ®Google Scholar
• Zintz C, Bok K, Parada E et al. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect. Genet. Evol.5(3), 281–290 (2005).
   PubMedGoogle Scholar
• Lew JF, Moe CL, Monroe SS et al. Astrovirus and adenovirus associated with diarrhea in children in day care settings. J. Infect. Dis.164(4), 673–678 (1991).
   PubMed Web of Science ®Google Scholar
• Mitchell DK. Astrovirus gastroenteritis. Pediatr. Infect. Dis. J.21(11), 1067–1069 (2002).
   PubMed Web of Science ®Google Scholar
• Iturriza-Gomara M, Clarke I, Desselberger U, Brown D, Thomas D, Gray J. Seroepidemiology of group C rotavirus infection in England and Wales. Eur. J. Epidemiol.19(6), 589–595 (2004).
   PubMed Web of Science ®Google Scholar
• Merck & Co. RotaTeq® Prescribing Information. Merck & Co. Inc., Whitehouse Station, NJ, USA (2009).
   Google Scholar